07/03/2024
"There are several reasons why I've always preferred CBGa/CBG for Autism. In a study conducted in 2018, researchers from Stanford University studied how compound anandamide levels in children with ASD compared to controls. They found that the concentration was significantly lower, a key finding as anandamide resembles THC in structure and functions similarly in the endocannabinoid system.
The study supports the theory that THC may hold therapeutic potential when used to treat autism symptoms but goes even further in proving that Clinical Endocannabinoid Deficiency Syndrome is playing the role and the acidic mother major, CBGa, is known to help balance issues out when Anandamide is lacking.
Another study in 2013 showed that endocannabinoid receptors in autistic children were found to be more active than those of healthy subjects, suggesting an imbalance within the endocannabinoid system.
Again, this points us toward the mother major cannabinoid CBGa, known for balancing the endocannabinoid system.
Research has supported that the same path to allowing a THC user to find efficacy again is the route to treating sensory processing issues that come with Autism."
-Mike Robinson, Founder Nanobles Corp. / Global Cannabinoid Research Center (GCRC) ResearcherOG.com **pMyMedicine
